Navigation Links
Hope for a rabies eradication strategy in Africa
Date:1/21/2009

Most of the rabies virus circulating in dogs in western and central Africa comes from a common ancestor introduced to the continent around 200 years ago, probably by European colonialists. In the current issue of Journal of General Virology a team of scientists from Africa, USA and France report that within this common ancestry there are distinct subspecies at country level and that there is only limited movement of virus between localities. These factors mean that, if neighbouring countries collaborate, a progressive strategy to eliminate rabies from this area of sub-Saharan Africa is possible.

Rabies causes over 24,000 deaths a year in Africa, mostly in poor rural communities and of children. Rabies prevention and treatment are costly and the necessary resources often scarce or inadequate. Controlling rabies in dogs, the main agents of rabies spread, is therefore an important part of any rabies eradication programme.

The team analysed 182 samples of dog rabies virus from 27 African countries taken over a time period of 29 years. Their analyses showed that the samples were of two types, which they call "Africa 1" and "Africa 2" with different geographical distribution and history, indicating a clear distinction between rabies viruses circulating in North Africa and those circulating in West/Central Africa. It appeared that "Africa 2" was introduced into the eastern part of West/Central Africa probably in Chad around 200 years ago and from there spread over the whole region, moving westwards and southwards, over a 100-year period. This spread follows the pattern of French colonial expansion in Africa. Distinct subpopulations of the virus exist in the different African countries and there is very little evidence that there is much movement of the virus among localities.

Dr Herv Bourhy, from the Institut Pasteur in Paris who led the research said:

"Some scientists have suggested that rabies outbreaks in Africa might be
'/>"/>

Contact: Dianne Stilwell
d.stilwell@sgm.ac.uk
44-020-897-76510
Society for General Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mitochondria could be a target for therapeutic strategy for Alzheimers disease patients
2. GUMC researchers hone in on new strategy to treat common infection
3. Effects of anthropogenic sound on marine mammals -- a research strategy
4. Scientists uncover Ebola cell-invasion strategy
5. New study raises concerns about proposed mitigation strategy for marine bycatch
6. Novel therapeutic strategy for colon cancer treatment
7. Insects evolved radically different strategy to smell
8. A built-in strategy for transgene containment
9. A screening strategy using zebrafish targets genes that protect against hearing loss
10. ETH Zurich competence center ESC introduces energy strategy
11. Strategy for nanotechnology-related environmental, health and safety research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...h researchers have measured CO2 levels for the pas...) over a sparsely inhabited rural area near Vallad...nd in the Iberian Peninsula, show that the levels ...r recent years, physicists and meteorologists have...) levels, and how these have evolved in the tropos...
(Date:12/2/2009)...ELPHIA Children exposed to secondhand cigarette s...cer in adulthood, even if they never smoked. , R...emiology, Biomarkers & Prevention , a journal of t...rt of a special tobacco focus in the December issu...s will be diagnosed with lung cancer; more than 15...
(Date:12/2/2009)...ELPHIA People who smoke their first cigarette wit...s of cotinine, a by-product of nicotine when proce...gardless of the number of cigarettes smoked. , ... of lung cancer, our results suggest that smokers ...ly at risk for lung cancer," said researcher Joshu...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Increased nicotine levels detected in those who light-up earlier 2Local farmers in Africa to benefit from school meal programs 59518 1Local farmers in Africa to benefit from school meal programs 59518 2Local farmers in Africa to benefit from school meal programs 59518 3 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 1New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 2
...ue, Czech Republic A new clinical trial suggests ...y used to treat hypertension, may significantly re...elated report by Penicka et al, "The effects of ca...tion in non-obstructive hypertrophic cardiomyopath...ary issue of The Journal of Molecular Diagnostics...
...ing at structures only atoms across, researchers h...l virus nanomotor. , Because of the motor,s stren...w findings could inspire engineers designing sophi...er of virus types may possess a similar motor, inc...ay also assist pharmaceutical companies developing...
... NEW YORK (DECEMBER 26, 2008) A team of ...vation Society (WCS) has reported a rapid recovery...he tsunami that devastated coastal regions through... The WCS team, working in conjunction with ...ce for Coral Reef Studies (ARCCoERS) along with go...
Other Biology News:Viruses, start your engines! 2Viruses, start your engines! 34 years after tsunami: Corals stage comeback 24 years after tsunami: Corals stage comeback 3
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...O, Sept. 29 Cadence Pharmaceuticals,Inc. (Nasdaq:...n-licensing,developing and commercializing proprie... hospital setting, announced today that the compan...ent the company,s corporate,overview on Monday, Oc...me),during the JMP Securities Third Annual Healthc...
...ology Medicaid Fraud Case; Qui Tam Whistleblower A...nt With Client,s Off-Label Marketing, Allegations ...llion Civil Settlement, $50 Million Corpor...Biotech drug manufacturer,Cephalon, Inc. ("Cephalo...or years by off-label marketing its first three pr...
..., Fla., Sept. 29 CPC of America, Inc.,(OTC Bullet...ained FTI,Capital Advisors, LLC, the investment ba...e strategic alternatives for the Company., As CPC...ors will report,to the Board any expressions of in...ible licensing agreement or acquisition of the Com...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 3CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities 2
...The CopyControl™ vector can be induced prior t...ctors provide the stability of single-copy BACs wi...r cloning vectors. The kits provide the linearized..., insert size screening system) necessary to creat...
Cell Wall Degrading Enzyme Complex Aspergillus sp. from Sigma-Aldrich
...Templates rich in GC content or with significant s...lify, and when subjected to PCR result in little o...an be increased by the addition of enhancing agent...an effective PCR enhancer for GC-rich templates.,...
...Application: The simple three step procedure (PCR,...sformation) can be completed in one day. The typic... than 80%. , Features and Benefits: , , Universal ...ector , High Cloning Efficiency - Typically>80% , ...
Biology Products: